Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00843180
Other study ID # H41337-33343
Secondary ID
Status Completed
Phase N/A
First received February 12, 2009
Last updated May 2, 2012
Start date November 2008
Est. completion date January 2010

Study information

Verified date May 2012
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Undergoing bone marrow transplantation (BMT) is associated with a high level of distress for patients and caregivers. Clinical research studies have reported benefits from massage for a) oncology patients, b) children, c) adults and children undergoing bone marrow transplants. A multi-center study of an intervention using a combination of massage therapy and a laugh cart to reduce distress in pediatric oncology patients undergoing BMT (PI: Phipps) is completed with results not yet published. There is still a need for independent studies to isolate the effect of massage for clinical outcomes (such as improved nausea and pain control) in children. Furthermore, this study will test the acceptability of an augmented massage intervention. In addition to provider-child massage, the augmented massage intervention includes training of the resident parent to provide additional parent-child massage, to relieve symptoms as needed. The goal of this augmented intervention is the improvement of symptom management in patients and decreased stress and feelings of helplessness in parents.

We propose a randomized pilot study at the UCSF pediatric bone marrow transplant center to assess the feasibility of a higher-quality study of the effects of massage in this population.

Aim 1: Determine the acceptability of a massage intervention for patients and parents on a pediatric bone marrow transplant unit.

Aim 2: Explore the logistics of implementing the augmented massage intervention at the bedside offered to consecutive patients over one year's time.

Aim 3: Collect preliminary data for patients and parents including patient clinical outcomes, quality of life, and satisfaction, and parental stress and mood to allow sample size calculations for further studies.


Description:

This study is a pilot randomized controlled feasibility trial of an augmented massage intervention, compared to a usual-care control group, in which intervention group participants will receive up to 3 massage sessions per week, during the 4-6 hospitalization at UCSF for Bone Marrow Transplant (BMT).

Participants will be approximately 24 children recruited from consecutive sample of pediatric cancer and non-cancer patients undergoing BMT age 5 to 18 admitted to UCSF children's hospital during one calendar year.

Intervention: Massage sessions will be gentle Swedish style combine with acupressure and will range from 20-45 minutes, provided by credentialed and trained massage therapists; augmentation will involve massage training for the resident parent, who rooms with the patient, to administer massage to his/her child during the course of the hospital stay. The control group will receive standard-care.

We will collect feasibility data and do exploratory comparison of clinical outcomes between groups.

Knowledge to be gained: We will have preliminary data for a larger trial that will determine whether an augmented massage intervention can support symptom management in the pediatric BMT unit.

B. Hypothesis(es): Briefly explain the hypothesis(es) to be tested. If the study is not designed to test a hypothesis, simply state "None." Hypothesis 1a: >60% of Patients are willing to be randomized to the massage study.

Hypothesis 1b: 80% of patients randomized to massage will accept the massage intervention when offered.

Hypothesis 1c: The majority of parents (>60%) are willing to learn massage techniques for use on their children.

Hypothesis 2a: Professional massage providers will be able to deliver massage, negotiating schedule, space, time, and other patient-related medical activities and will be able to schedule >50% of planned massages.

Hypothesis 2b: Massage providers will be able to assess the acceptable time period for massage (between 10 minutes and 45 minutes).

Hypothesis 2c: Parents will carry out the massage on their children, will do at least 5 massages over the study period and are willing to provide a self-report of estimated time engaged in massage.

Hypothesis 3a: 80% of patients will answer survey questions about their experience in general and the massage intervention.

Hypothesis 3b: The RA will be able to collect clinical data from chart review and electronically stored lab data .

Hypothesis 3c: 80% of parents will answer survey questions about their experience in learning and delivering massage, stress, mood, PTSD symptoms and self-efficacy around patient management.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date January 2010
Est. primary completion date January 2010
Accepts healthy volunteers No
Gender Both
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria:

- Being 5 to 18 years old

- Admitted for BMT.

Rationale: This is a pediatric study for children up to age 18 admitted to the BMT unit. Questionnaires are not designed for children under age 5.

Exclusion Criteria:

- Parent or child unable to answer questionnaire due to language limitations.

Rationale: The pilot character of the study with its limited budget does not include instruments in foreign languages, such as Chinese or Spanish. This could be a project for further studies.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
massage
one to three massages per week by massage practitioner additional massages by resident parent who is being taught to massage her/his child

Locations

Country Name City State
United States Childrens' Hospital UCSF San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Days With Pain Scores >3 Measured on Numeric Rating Scale (Range 0-10; 0 for no Pain; 10 for Worst Pain Imaginable) days of pain >3 by nurses notes based on pain scores on numeric rating scale (up to 28 days) 7 days pre to 21 days post transplant = 28 days No
Secondary Number of Vomiting Episodes number of vomiting episodes as reported by nurses per occurence (no upper limit) day -7 to +21 around transplant date No
Secondary Days of Hospital Stay days of hospital stay after bone marrow transplant (up to 100 days; participant observation was censored after 100 days) days of hospital stay after bone marrow transplant No
Secondary Days to Recovery Neutrophil Count number of days to recovery neutrophil count >500 cells per microliter for 2 consecutive days (range, up to 100 days, censored at 100 days) hospital stay No
See also
  Status Clinical Trial Phase
Recruiting NCT06148610 - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Completed NCT02212236 - Psychological Intervention for Distress During HSCT Phase 2
Completed NCT00023530 - Blood and Marrow Transplant Clinical Research Network N/A
Completed NCT01466335 - An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers Phase 1
Withdrawn NCT02682953 - Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers Phase 2
Completed NCT00775632 - Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants Phase 2
Completed NCT00048256 - Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates N/A
Completed NCT00004994 - Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant N/A
Completed NCT04039100 - Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease N/A
Completed NCT04535570 - Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
Recruiting NCT06118853 - Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT N/A
Active, not recruiting NCT01016093 - Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients Phase 2/Phase 3
Completed NCT01015183 - Prevention Chemotherapy Induced Mucositis by Zinc Sulfate Phase 2/Phase 3
Completed NCT00000591 - T-Cell Depletion in Unrelated Donor Marrow Transplantation Phase 3
Completed NCT04474730 - Physical Activity Monitoring Among BMT Patients N/A
Completed NCT02733744 - Fecal Microbiota Transplantation After HSCT Early Phase 1
Active, not recruiting NCT02319226 - Toward Immune Biomarkers for Tolerance and GvHD in Humans
Recruiting NCT00673348 - Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations N/A
Completed NCT00005556 - Retention of Bone Marrow Donors in a National Registry N/A
Completed NCT05391347 - Effects of Orange Oil Aromatherapy on the Pain and Anxiety N/A